Non-alcohol induced steatohepatitis in non-obese patients: Treatment with ursodeoxycholic acid

被引：9
作者：
Bauditz, J [1 ]
Schmidt, HHJ [1 ]
Dippe, P [1 ]
Lochs, H [1 ]
Pirlich, M [1 ]
机构：
[1] Univ Klinikum Berlin, Charite, Med Klin Schwerpunkt Gastroenterol Hepatol & Endo, Berlin, Germany
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 05期
关键词：
D O I：
10.1111/j.1572-0241.2004.40013.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：959 / 960
页数：2
相关论文
共 50 条
  • [41] Non-alcoholic Fatty Liver Disease in Non-obese Patients
    Christopher J. Schmoyer
    Mohammad S. Siddiqui
    Current Hepatology Reports, 2017, 16 (4) : 382 - 390
  • [42] Obese and non-obese patients with severe asthma: Comparison of omalizumab-mepolizumab treatment outcomes
    Ozden, S.
    Merve, T. Fatma
    Orcen, C.
    Yakut, T.
    ALLERGY, 2023, 78 : 157 - 157
  • [43] Exercise-induced bronchospasm (EIB) in obese and non-obese adolescents
    Lopes, WA
    Leite, N
    Santos, GC
    Prestes, AL
    Dressler, VF
    Rosario, NA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S4 - S4
  • [44] DIETARY INDUCED PRIMARY HYPERTRIGLYCERIDEMIA IN NON-OBESE RATS
    REAVEN, G
    CHEN, I
    RISSER, T
    REAVEN, E
    CLINICAL RESEARCH, 1978, 26 (02): : A160 - A160
  • [45] The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
    Nakamuta, Makoto
    Kohjima, Motoyuki
    Higuchi, Nobito
    Kato, Masaki
    Kotoh, Kazuhiro
    Yoshimoto, Tsuyoshi
    Yada, Masayoshi
    Yada, Ryoko
    Takemoto, Ryosuke
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Nakashima, Manabu
    Enjoji, Munechika
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 22 (05) : 663 - 667
  • [46] A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients
    Harrison, SA
    Fincke, C
    Helinski, D
    Torgerson, S
    Hayashi, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) : 623 - 628
  • [47] Ursodeoxycholic acid in the treatment of non-alcoholic steatohepatitis: Results of a prospective clinical controlled trial.
    Guma, C
    Viola, L
    Thome, M
    Galdame, O
    Alvarez, E
    HEPATOLOGY, 1997, 26 (04) : 1036 - 1036
  • [48] Comparison of risk factors for nonalcoholic steatohepatitis and advanced fibrosis between patients with obese and non-obese nonalcoholic fatty liver disease
    Kim, W.
    Joo, S. K.
    Kim, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S597 - S597
  • [49] THE EFFICACY OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS: A 15-YEAR SYSTEMATIC REVIEW
    Mappala, Higinio
    GUT, 2019, 68 : A152 - A153
  • [50] Characteristics, treatment and outcomes of obese vs non-obese dilated cardiomyopathy
    Bianchi, L. Lorenzo
    Toma, M.
    Solimano, M.
    Bertero, E.
    Porto, I.
    Canepa, M.
    Ameri, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 77 - 77
12345